Paclitaxel and gemcitabine for refractory or relapsed small cell lung cancer (SCLC). A multicentric phase II study

✍ Scribed by M. Domine; J. Gonzalez Larriba; R. Garcia Gomez; S. Morales; D. Isla; C. Garcia Giron; I. Maestu; V. Giner; S. Terrasa; J. Andrade; R. Alfonso; F. Lobo

• Book ID: 117658082
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 339 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80712-7